Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 29941 | Clinical Psychopharmacology and Neuroscience | 4.3 | Q2 | Korean College of Neuropsychopharmacology | 60.0% 228/580 Psychiatry and Mental Health | 1303 | 303 |
| 29942 | PharmaNutrition | 4.2 | Q2 | Elsevier | 60.0% 159/404 Food Science | 516 | 123 |
| 29943 | Research Results in Biomedicine | 1.9 | Q2 | Belgorod State National Research University | 59.0% 19/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 302 | 160 |
| 29944 | American Journal of Therapeutics | 4.6 | Q2 | Wolters Kluwer Health | 59.0% 112/275 Pharmacology (medical) | 901 | 195 |
| 29945 | Drugs of Today | 4.6 | Q2 | Clarivate | 59.0% 111/275 Pharmacology (medical) | 542 | 117 |
| 29946 | Human Psychopharmacology | 4 | Q2 | John Wiley & Sons | 58.0% 241/580 Psychiatry and Mental Health | 506 | 127 |
| 29947 | Clinica e Investigacion en Arteriosclerosis | 3.7 | Q2 | Sociedad Espanola de Arteriosclerosis | 58.0% 167/397 Cardiology and Cardiovascular Medicine | 692 | 188 |
| 29948 | Expert Opinion on Pharmacotherapy | 4.6 | Q2 | Taylor & Francis | 58.0% 114/275 Pharmacology (medical) | 3399 | 743 |
| 29949 | Biopharmaceutics and Drug Disposition | 4.4 | Q2 | John Wiley & Sons | 57.0% 117/275 Pharmacology (medical) | 505 | 114 |
| 29950 | Hospital Pharmacy | 1.8 | Q2 | Thomas Land Publishers Inc. | 56.0% 21/47 Pharmacy | 688 | 391 |
| 29951 | Cardiology (Switzerland) | 3.5 | Q2 | Karger | 56.0% 173/397 Cardiology and Cardiovascular Medicine | 977 | 276 |
| 29952 | Journal of Infection and Chemotherapy | 4.3 | Q2 | Elsevier | 56.0% 120/275 Pharmacology (medical) | 4523 | 1051 |
| 29953 | Pharmacoepidemiology and Drug Safety | 3.7 | Q2 | John Wiley & Sons | 55.0% 71/158 Epidemiology | 2464 | 664 |
| 29954 | Current Cardiovascular Risk Reports | 4.2 | Q2 | Springer Nature | 55.0% 123/275 Pharmacology (medical) | 368 | 87 |
| 29955 | Clinical Pharmacology in Drug Development | 3.8 | Q2 | John Wiley & Sons | 54.0% 84/185 Pharmaceutical Science | 2092 | 551 |
| 29956 | Journal of Pharmacy Practice and Research | 1.7 | Q2 | John Wiley & Sons | 54.0% 22/47 Pharmacy | 310 | 182 |
| 29957 | Anti-Cancer Drugs | 4.1 | Q2 | Wolters Kluwer Health | 54.0% 127/275 Pharmacology (medical) | 2632 | 644 |
| 29958 | European Journal of Drug Metabolism and Pharmacokinetics | 4.2 | Q2 | Springer Nature | 54.0% 125/275 Pharmacology (medical) | 1031 | 248 |
| 29959 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | 3.6 | Q2 | Mary Ann Liebert | 53.0% 86/185 Pharmaceutical Science | 489 | 136 |
| 29960 | International Journal of STD and AIDS | 2.6 | Q2 | SAGE | 53.0% 69/147 Dermatology | 1593 | 624 |
| 29961 | Drug Metabolism and Personalized Therapy | 2.4 | Q2 | Walter de Gruyter | 53.0% 36/77 General Pharmacology, Toxicology and Pharmaceutics | 289 | 119 |
| 29962 | Research Journal of Pharmacy and Technology | 1.5 | Q2 | A and V Publication | 53.0% 22/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 6229 | 4088 |
| 29963 | Chemotherapy | 4 | Q2 | Karger | 53.0% 166/357 Infectious Diseases | 480 | 121 |
| 29964 | Precision Cancer Medicine | 2.1 | Q2 | AME Publishing Company | 52.0% 269/568 Surgery | 175 | 84 |
| 29965 | Journal of Pediatric Pharmacology and Therapeutics | 2.2 | Q2 | Pediatric Pharmacy Advocacy Group, Inc. | 52.0% 164/342 Pediatrics, Perinatology and Child Health | 899 | 408 |
| 29966 | Journal of Applied Pharmaceutical Science | 2.3 | Q2 | Open Science Publishers LLP Inc. | 51.0% 211/433 Medicine (miscellaneous) | 2393 | 1060 |
| 29967 | Contemporary Clinical Trials | 3.8 | Q2 | Elsevier | 51.0% 134/275 Pharmacology (medical) | 4091 | 1080 |
| 29968 | Nanomedicine Research Journal | 3.2 | Q2 | Tehran University of Medical Sciences | 50.0% 85/171 Internal Medicine | 444 | 138 |
| 29969 | Psychopharmacology Bulletin | 3.3 | Q3 | MedWorks Media LLC | 49.0% 294/580 Psychiatry and Mental Health | 348 | 107 |
| 29970 | Drug Metabolism and Bioanalysis Letters | 2.9 | Q3 | Bentham Science Publishers | 48.0% 96/185 Pharmaceutical Science | 163 | 57 |